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Abstract
Background/Aims: Alpha-synuclein (α-Syn) is a neuronal protein that is highly implicated in
Parkinson’s disease (PD), and protein phosphatase 2A (PP2A) is an important serine/threonine
phosphatase that is associated with neurodegenerative diseases, such as PD. α-Syn can
directly upregulate PP2A activity, but the underling mechanism remains unclear. Therefore,
we investigated the molecular mechanism of α-Syn regulating PP2A activity. Methods: α-Syn
and its truncations were expressed in E.coli, and purified by affinity chromatography. PP2A
Cα and its mutants were expressed in recombinant baculovirus, and purified by affinity
chromatography combined with gel filtration chromatography. The interaction between
α-Syn and PP2A Cα was detected by GST pull-down assay. PP2A activity was investigated
by the colorimetric assay. Results: The hydrophobic non-amyloid component (NAC) domain
of α-Syn interacted with PP2A Cα and upregulated its activity. α-Syn aggregates reduced its
ability to upregulate PP2A activity, since the hydrophobic domain of α-Syn was blocked during
aggregation. Furthermore, in the hydrophobic center of PP2A Cα, the residue of I123 was
responsible for PP2A to interact with α-Syn, and its hydrophilic mutation blocked its interaction
with α-Syn as well as its activity upregulation by α-Syn. Conclusions: α-Syn bound to PP2A Cα
by the hydrophobic interaction and upregulated its activity. Blocking the hydrophobic domain
of α-Syn or hydrophilic mutation on the residue I123 in PP2A Cα all reduced PP2A activity
upregulation by α-Syn. Overall, we explored the mechanism of α-Syn regulating PP2A activity,
which might offer much insight into the basis underlying PD pathogenesis.
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Published by S. Karger AG, Basel
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Introduction

Alpha-synuclein (α-Syn), encoded by the SNCA gene [1-3], contributes to brain
neuroplasticity and neurodegeneration, which is implicated as being causative factor for
neurodegenerative disorders, including Parkinson’s disease (PD), dementia with Lewy bodies
(DLB), as well as multiple system atrophy (MSA) [4-6]. α-Syn is abundantly expressed in the
central nervous system, mainly at presynaptic terminal in mammalian brains. Structurally,
α-Syn can usually be divided into three parts: the N terminus (residues 1-60), which contain
four 11-amino acid imperfect repeats (coding for amphipathic α-helices) with a conserved
motif (KTKEGV); the central hydrophobic non-amyloid component (NAC, residues 61-95),
which contain three additional KTKEGV repeats; and the C terminus (residues 96-140), in
which acidic residues and prolines are highly enriched [7-9]. The N terminus, with lipidbinding motifs KTKEGV, is predicated to form α-helical structure for interaction with lipidic
membranes [7, 10, 11]. Most of the mutants associated with PD, such as A53T, exist in this
region [12]. The NAC domain is responsible for its misfolding and aggregation [8, 13]. The C
terminus is thought to contain protein-protein and protein-small molecule interaction sites
[14-16]. α-Syn not only regulates the release of neurotransmitters, but also regulates the
activity of many proteins, such as protein phosphatase 2A (PP2A)[17-19].
PP2A is an important serine/threonine phosphatase, and it is comprised of three
subunits: a 65-kD structural subunit A, a variable regulatory subunit B, and a 36-kD
catalytic subunit C [20-25], and the subunit C has a unique catalytic activity. PP2A can
directly dephosphorylate numerous substrates, such as tyrosine hydroxylase (TH) [26,
27], extracellular-regulated kinases (ERK1/2) [28], and tau protein [29-31]. PP2A is a
key regulator in neurodegenerative diseases [32-36]. In Alzheimer’s disease (AD), the
downregulation of PP2A activity could increase the phosphorylation of tau protein, raise the
formation of amyloid precursor protein, and increase the missing of neurons [37-39]. In PD,
the upregulation of PP2A activity could reduce the phosphorylation of TH, which leads to the
decrease of dopamine [17].
Previous studies showed that α-Syn could upregulate the activity of PP2A which further
reduce TH phosphorylation in dopaminergic cells [17, 40], but the underlying structural
mechanism of α-Syn regulating PP2A activity remains unclear.
In this study, to gain insight into the precise manner by which α-Syn bind to PP2A to
stimulate its activity, we proposed a hypothesis that α-Syn could bind to PP2A Cα by the
hydrophobic interaction and then upregulate its activity. To confirm our hypothesis, we
firstly constructed α-Syn truncates, and found that the NAC domain of α-Syn interacted with
PP2A Cα and upregulated PP2A activity. Second, after blocking the NAC domain by forming
α-Syn aggregates, we found α-Syn aggregates less stimulated PP2A activity than monomers.
Finally, we defined the definite residue within PP2A Cα which was responsible for its
interaction with α-Syn, and its association with PP2A activity regulation by α-Syn. In short,
the data showed that NAC domain of α-Syn could bind to the hydrophobic center of PP2A Cα,
particularly the residue I123, to stimulate PP2A activity. These results might offer insight
into the mechanistic basis of PD pathogenesis.
Materials and Methods

Plasmid constructs
The cDNA encoding the α-Syn and its truncates were subcloned into the pCMV-myc vector. The
mutants of α-Syn (A53T) and PP2A Cα (I123S, W200S, L243S, Y265S and C269S) were performed using
the PCR-based Quik Change method of site-directed mutagenesis with Phusion DNA polymerase (Agilent
Technologies). These mutations were confirmed by sequencing the entire coding region.
To make α-Syn-GLuc constructs, α-Syn was subcloned into the fragments of humanized Gaussia
princeps luciferase (1-93; 94-169) to generate α-Syn-GLuc-N and α-Syn-GLuc-C fusion constructs. For the
A53T-GLuc-N and A53T-GLuc-C fusion constructs, they were generated by the similar method.
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Cell cultures and transfection
Human SK-N-SH neuroblastoma cells obtained from the American Type Culture Collection were grown
in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS,
Gibco) at 37°C under 5% CO2. The transient transfections were performed by lipofection with polyetherimide
(PEI, Polysciences).

Western blot
After transfection, cells were washed with ice-cold phosphate-buffered saline (PBS, Origene) and
homogenized them in ice-cold lysis buffer (15 mM Tris, 0.25 M sucrose, 2 mM EDTA, 1 mM EGTA, 10 mM
Na3VO4, 25 mM NaF, 10 mM sodium pyrophosphate, and protease inhibitor, pH 7.6) for 30 min. Then
homogenates were centrifuged at 12, 000 g for 30 min and the supernatant fraction was collected for
analysis. The protein concentration was determined using a bicinchoninic acid protein assay kit (Pierce
Biotechnology) according to the manufacturer’s instructions. The samples were resolved on 10% SDS
polyacrylamide gels and transferred to PVDF membranes (Millpore). The membranes were probed with
the following primary antibodies: mouse anti-β-actin (1:2, 000, GuanXingYu), mouse anti-α-Syn (1:2000,
BD), mouse anti-myc (1:5000, Clontech). These primary antibodies were revealed by infrared-conjugated
IgG IRDye 680RD (1:10000, LI-COR Bioscience) or 800CW (1:10000, LI-COR Bioscience). Protein bands
were detected using an Odyssey Infrared Imaging system (LI-COR Bioscience), and analyzed with Image J
software (imagej.nih.gov/ij/).
Immunofluorescence and confocal microscopy
24 h after transfection with the indicated plasmids, SK-N-SH cells were washed with PBS, fixed with
4% paraformaldehyde for 20 min, washed in PBS again, and permeabilized with 0.3% Triton X-100 in PBS
for 25 min at room temperature. After blocking with 10% normal goat serum for 1 h, cells were incubated
with mouse anti-myc (1:2000, Clontech) overnight at 4°C, followed by incubation with Alexa Fluor
488-conjugated secondary antibody (1:500, Life Technologies) for 1 h at room temperature. Cell nuclei were
visualized by staining with DAPI (1:1000, Sigma). The cells were imaged using a confocal microscope (Leica
Microsystems).

Protein expression and purification
The cDNA encoding full-length α-Syn and its truncates were subcloned into pGEX4T-1 vector
(Invitrogen), and expressed in E.coli strain BL21 cells. 0.1 mM Isopropyl β-D-galactopyranoside (IPTG) was
added to bacterial cultures grown at 27°C. The lysates were centrifuged at 12, 000 g for 40 min, then the
supernatants were incubated with glutathione-sepharose 4B beads (GE Healthcare) at 4°C. After 3 h, the
beads were collected and washed 3 times. The GST fusion proteins were eluted by buffer containing 50 mM
Tris-HCl and 10 mM reduced glutathione (pH 8.0). The purified GST fusion proteins were stored at -80°C.
The cDNA encoding PP2A Cα and its mutants were subcloned into pFastbac vector (Invitrogen),
transformed into E.coli strain DH10Bac cells, and isolated the recombinant bacmid DNA. Then transfect
recombinant bacmid DNA into SF9 cells, harvest the recombinant baculovirus, and express the baculovirus
in SF9 cells. The cell lysates were harvested 3 days after infection with P2 baculovirus, and centrifuged at
12, 000 g for 15 min, then the supernatants were incubated with Ni-Sepharose 6 beads (GE Healthcare) at
4°C. After 2.5 h, the beads were collected and washed 3 times. The His fusion proteins were eluted by buffer
containing 50 mM sodium phosphate, 300 mM NaCl and 300 mM imidazole (pH 7.0). Then, the protein
was further purified by gel filtration through a Superdex 75 column, during which the imidazole had been
desalted, and the buffer was exchanged into Tris buffer (50 mM Tris-HCl, pH 8). The purified His fusion
proteins were finally concentrated by Amicon Ultra-4 Centrifugal Filter Devices (Merck Millipore) and
stored at -80°C.

PP2A activity assay
The activity of PP2A was measured using a PP2A Colorimetric Assay kit (GenMed Scientifics Inc). This
assay is based on the release of free phosphate during the dephosphorylation of RKpTIRR by endogenous
PP2A, detected by a chromogenic reaction with molybdenum blue produced by a ferrous sulfate reduction.
In brief, samples were incubated for 20 min at 30℃ in the assay buffer containing 50 mM Tris-HCI pH 8,
0.1 mg/ml BSA, 1 mM β-mecaptoethanol (BME) and 40 µM substrate RKpTIRR. To terminate the reaction,
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molybdenum blue solution was added to the mixture. The mixture was incubated for 15 min at 30℃ to allow
color development. The free phosphate concentration was measured at 660 nm using a spectrophotometer
(Bio-Rad), and the phosphate concentration was converted to PP2A activity/mg protein as described in the
instructions.

GST pull-down assay
The GST pull-down assays were carried out as described [41, 42]. In brief, the proteins with GST tag
were incubated with glutathione beads for 1 h at 4°C, and washed 5 times with PBS. Then PP2A Cα or its
mutants were subjected to GST pull-down with GST or GST fusion proteins for 3 h at 4°C. The products
were centrifuged at 1000 g for 5 min at 4°C. Samples were washed 5 times with PBS. After the final wash,
glutathione-bound proteins were eluted by adding of loading buffer and boiling for 10 min. Eluted proteins
were separated by SDS-PAGE gels with the corresponding antibodies, such as mouse anti-His (1:5000,
Clontech) and mouse anti-GST (1:10000, Novagen).
Transmission electron microscopy (TEM)
α-Syn aggregates were fixed on Formvar coated copper grids for 2 min, stained with 2% uranyl acetate
solution for 5 min, washed in 0.1 M PBS for 3 times, air dried, and observed by a JEOL transmission electron
microscope.

Protein-fragment complementation assay
Fusion constructs for α-Syn (α-Syn-GLuc-N, α-Syn-GLuc-C), and for A53T (A53T-GLuc-N, A53T-GLuc-C)
were generated and the respective paired constructs were transfected into SK-N-SH cells in a 96-well plate
format. 24 h after transfection, cells were washed with PBS and replaced with phenol-red free medium.
Luciferase activity from protein complementation was measured for live cells in an automated plate reader
at 480 nm following the injection of the cell permeable substrate, coelenterazine (20 μM) (Sigma) with a
signal integration time of 2 s.
Computational docking
The computational model of the interaction between α-Syn to PP2A Cα was accomplished using online
protein-protein dock server, ZDOCK 3.0.2 (http://zdock.umassmed.edu/). The amino acid sequences of
human α-Syn (PDBID: 1XQ8) and PP2A Cα (PDBID: 2IAE chain C) were downloaded from the NCBI website,
and uploaded to the server. The final image of the model was downloaded and visualized by Discovery
Studio Visualizer 4.0 (BIOVIA, San Diego, CA, USA).
Statistics
Statistical analyses were performed using Prism software, version 6 (GraphPad). Differences between
groups were assessed by ANOVA. Data are expressed as mean ± SEM for at least three independent
experiments, and significance was considered when p value was less than 0.05.

Results

α-Syn directly interacted with PP2A Cα and upregulated its activity
Previous studies have shown that α-Syn could interact with PP2A Cα and upregulate
PP2A activity [17, 40]. To reproduce this effect, we firstly expressed and purified these
two proteins. α-Syn, with GST tag, was expressed in E.coli, and then purified by affinity
chromatography with glutathione-sepharose beads (Fig. 1A). For PP2A Cα, it was expressed
in recombinant insect baculovirus, and then purified by affinity chromatography with Nisepharose beads combined with gel filtration chromatography (Fig. 1B). In order to confirm
the direct interaction between α-Syn and PP2A Cα, we performed GST pull-down assay after
incubation of these two purified proteins. As shown in Fig. 1C, α-Syn pulled down PP2A Cα,
while no signal was observed in the GST group as control, demonstrating that α-Syn could
directly interact with PP2A Cα.
Subsequently, we detected the effect of α-Syn on PP2A activity. For this purpose, α-Syn
protein was firstly obtained by cleaving the GST tag from the fusion protein of α-Syn/GST

2616

Physiol Biochem 2018;47:2613-2625
Cellular Physiology Cell
© 2018 The Author(s). Published by S. Karger AG, Basel
DOI: 10.1159/000491657
and Biochemistry Published online: July 11, 2018 www.karger.com/cpb
Qu et al.: Alpha-Synuclein Upregulating Protein Phosphatase 2A Activity
Fig.1

Fig. 1. α-Syn interacted with PP2A Cα and upregulated
its activity. (A-B) The purified α-Syn protein (A) and PP2A
Cα protein (B) were detected by the coomassie brilliant
blue (CBB) staining of SDS-PAGE gels. (C) The interaction
between α-Syn and PP2A Cα was detected by GST pulldown assay. Purified α-Syn protein was incubated with
PP2A Cα protein, then the compounds were separated by
SDS-PAGE gels. Anti-His and anti-GST blots showed input
and pull-down fractions in GST pull-down assay. Input,
PP2A Cα. (D) Purified α-Syn protein was incubated with
PP2A Cα for 0.5 h, then PP2A activity was detected using
colorimetric assay. **p<0.01, n=5. (E) The plasmids pCMVmyc-α-Syn and pCMV-myc were transiently transfected
into SK-N-SH cells for 24 h. The protein level of α-Syn
was detected by western blotting. β-actin was used as a
loading control (F) 24 h after plasmid transfection into
SK-N-SH cells, the PP2A activity regulation by α-Syn was detected by colorimetric assay. **p<0.01, n=5.

(Fig. 1A). Then α-Syn protein (0.5 mg/ml) was incubated with PP2A Cα (0.5 mg/ml), and
PP2A activity was measured by colorimetric assay. As shown in Fig. 1D, the PP2A activity
in response to α-Syn was two-fold higher than the baseline PP2A activity, which implied
that α-Syn could upregulate PP2A activity. To further confirm the above results in cells, the
plasmids pCMV-myc-α-Syn and the empty plasmids pCMV-myc were transiently transfected
into SK-N-SH cells respectively. First, the protein level of α-Syn was detected by western
blotting to make sure they were at comparable level. (Fig. 1E). Then the effect of α-Syn on
PP2A activity was detected. The results showed that the PP2A activity in α-Syn-transfected
group was larger than that in blank vector group and non-treatment group, which suggested
that α-Syn could upregulate PP2A activity in cells (Fig. 1F). Together, the results indicated
1
that α-Syn could directly interact with PP2A Cα and upregulate its activity.

The NAC domain of α-Syn directly interacted with PP2A Cα
α-Syn is usually divided into three domains: the N terminus (residues 1-60), the NAC
domain (residues 61-95), and the C terminus (residues 96-140) (Fig. 2A) [7, 8, 43]. Since
the above experiments indicated that α-Syn could directly interact with PP2A Cα, we
questioned which terminus of α-Syn was associated with its interaction with PP2A Cα. To
address this question, α-Syn truncates were constructed, expressed in E.coli, and purified
by affinity chromatography with glutathione-sepharose beads (Fig. 2B). Then we detected
the interaction between α-Syn truncates and PP2A Cα by GST pull-down assay. The results
showed that the NAC domain of α-Syn pulled down PP2A Cα, while the N terminus and C
terminus could not (Fig. 2C). Statistically, the level of PP2A Cα, pulled down by the NAC
domain and full length α-Syn, were significantly higher compared with the other groups (Fig.
2D). To further confirm this observation, we then replaced the NAC domain of α-Syn with the
homologous region from β-Syn to get the chimera α-Syn-NAC-swap. Since it demonstrated
that the NAC domain was responsible for α-Syn to interact with PP2A Cα, we hypothesized
that the chimera α-Syn-NAC-swap should not exhibit its interaction with PP2A Cα. Indeed,
our GST pull-down experiment indicated that the chimera α-Syn-NAC-swap could not pull
down the protein of PP2A Cα (Fig. 2E-F). Together, these results suggested the NAC domain
of α-Syn could directly interact with PP2A Cα.
The NAC domain of α-Syn was responsible for the PP2A activity regulation
Since the NAC domain of α-Syn could directly interact with PP2A Cα, then we asked if
it could also upregulate the activity of PP2A. For this purpose, the purified α-Syn truncated
proteins (0.5 mg/ml) were incubated with PP2A Cα (0.5 mg/ml) respectively, then PP2A
activity was measured by colorimetric assay. As shown in Fig. 3A, the PP2A activity in the
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groups of α-Syn and α-Syn-NAC was higher than the baseline PP2A activity, while the PP2A
activity in the group of α-Syn-N and α-Syn-C was similar with the baseline. These data implied
that the NAC domain of α-Syn could upregulate PP2A activity, but the N and C terminus had
almost no effect on PP2A activity.
To further confirm the effect of α-Syn truncations on PP2A activity in cells, the
plasmids encoding α-Syn truncations were transiently transfected into SK-N-SH cells.
First, the expression level of α-Syn truncations in transfected cells was confirmed by
immunocytochemistry (Fig. 3B) and dot blotting (Fig. 3C). Then PP2A activity in transfected
cells was measured by the colorimetric assay, and the results showed that the PP2A activity in
full length α-Syn and α-Syn-NAC-transfected cells were larger than that in vector-transfected
cells, while the PP2A activity in the α-Syn-N and α-Syn-C-transfected cells was similar
Fig. 2

Fig. 2. The NAC domain of α-Syn interacted with
PP2A Cα. (A) The model of α-Syn truncations. (B) The
purified proteins of α-Syn truncations were detected
by CBB staining of SDS-PAGE gels. (C) GST pulldown assay was performed to detect the interaction
between α-Syn truncations and PP2A Cα. Purified
α-Syn truncates were incubated with PP2A Cα, then
the compounds were separated by SDS-PAGE gels.
Anti-His and anti-GST blots showed input and pulldown fractions in GST pull-down assay. Input, PP2A
Cα. (D) Quantitative analysis of the percentage
of PP2A Cα pull-down by α-Syn truncations was
performed. (E) After replacing the NAC domain of
α-Syn with the homologous region from α-Syn to
get the chimera α-Syn-NAC-swap, the interaction
between this chimera and PP2A Cα was analyzed by
GST pull-down assay. The purified chimera protein
α-Syn-NAC-swap was incubated with PP2A Cα, then
the compounds were separated by SDS-PAGE gels.
Anti-His and anti-GST blots showed input and pulldown fractions in GST pull-down assay. Input, PP2A
Cα. (F) Quantitative analysis of the percentage of PP2A Cα pull-down by α-Syn-NCA-swap was performed.
**p<0.01, n=5.

Fig. 3. The NAC domain of α-Syn upregulated the
activity of PP2A. (A) The purified full length α-Syn
and its truncations were incubated with PP2A
Cα for 0.5 h, then PP2A activity was detected by
colorimetric assay. **p<0.01, n=5. (B) The plasmids
of α-Syn and its truncations (pCMV-myc-α-Syn,
pCMV-myc-α-Syn-N, pCMV-myc-α-Syn-M, pCMVmyc-α-Syn-C) were transfected into SK-N-SH cells
respectively. After transfection 24 h, cells were
fixed and stained with anti-myc antibodies (green).
The nucleus was stained by DAPI (blue). Scale
bar, 25 μm. (C) The protein level of α-Syn and its
truncations in SK-N-SH cells was detected by dot
blotting after transfection for 24 h. (D) 24 h after
transfection of α-Syn and its truncation plasmids
into SK-N-SH cells, PP2A activity was detected by
colorimetric assay. **p<0.01, n=5.

Fig.3
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with that in vector-transfected group (Fig. 3D). The above results suggested that the NAC
domain of α-Syn, like the full length of α-Syn, could upregulate PP2A activity, while the N and
C terminus could not. These data confirmed that the NAC domain of α-Syn, containing the
hydrophobic amino acid, was responsible for regulating PP2A activity, which was consistent
with the results in vitro.

Blocking the NAC domain of α-Syn declined its regulating effect on PP2A activity
Since the NAC domain of α-Syn could upregulate PP2A activity, we hypothesized that
blocking the NAC domain might decline its regulating effect on the activity of PP2A. As we
know, α-Syn is a natively unfolded protein with a tendency to aggregate by the hydrophobic
interaction [8, 13, 44]. After aggregation, the hydrophobic domain of α-Syn may be blocked,
so α-Syn aggregates should less upregulate the PP2A activity than monomers. To test our
hypothesis, α-Syn aggregates were firstly generated from purified recombinant α-Syn in
vitro at 37°C for 72 h with continuous shaking. Electron microscope imaging further verified
the morphology of α-Syn aggregates, and the results showed α-Syn aggregates were large,
broad and had a ribbon-like shape fibrils, but the fibril-like structure were not detected in
α-Syn monomer sample (Fig. 4A). Then the PP2A activity in response to α-Syn aggregates
was measured by colorimetric assay, and the results showed that PP2A activity response to
α-Syn aggregates was much lower than that of α-Syn monomers, indicating that aggregates
could less stimulate PP2A activity than monomers (Fig. 4B).
Next, we further confirm that α-Syn aggregates less stimulated the PP2A activity
than monomers in cells. A53T, the first mutant of α-Syn associated with PD, had a more
propensity to form aggregates [45], and we also further confirmed that A53T mutant could
form aggregates more efficiently than WT α-Syn in vitro (Fig. 4C). So, we speculated that
A53T could less upregulate PP2A activity in cells, compared with wild type (WT) α-Syn. In
this scenario, we first adopted a protein-fragment complementation assay (PCA) to prove
that A53T was more prone to aggregate than WT α-Syn. For this purpose, WT α-Syn or A53T
mutant were fused to the amino-terminal (1-93) or carboxy-terminal (94-169) fragments of
Gaussia princeps luciferase (GLuc) respectively [46], to generate α-Syn-GLuc-N, α-Syn-GLuc-C
or A53T-GLuc-N, A53T-GLuc-C constructs. The two paired fusion proteins could reconstitute
when brought together during α-Syn aggregation [47, 48] (Fig. 5A). So the SK-N-SH cells may
be transfected with these paired constructs for analysing the α-Syn aggregation level. First,
to evaluate the expression level of these proteins, we adopted the western blotting and the
results indicated that the levels of these proteins were similar on immunoblots (Fig. 5B). After
Fig.4

Fig. 4. α-Syn aggregates could less stimulate PP2A activity than monomers. (A)
Electron microscope images of α-Syn
monomers (the upper) and aggregates
(the lower). Scale bar, 200 nm. (B) α-Syn
aggregates and monomers were incubated with PP2A Cα for 0.5 h respectively,
then PP2A activity was detected in vitro by colorimetric assay kit. (C) Kinetic
analysis of the aggregation of α-Syn and
its mutant A53T using thioflavin T (ThT)
fluorescence assay. α-Syn and its mutant
A53T proteins were dissolved to a concentration of 360 µM (around 5 mg/mL)
respectively in the assembly buffer (50
mM Tris/100 mM NaCl, pH 7.0). The reaction mixtures were incubated at 37°C with constant agitation (1000 rpm) for two days and the rate of aggregation was monitored using the ThT fluorescence assay (excitation at 450 nm, 2.5 nm slit, and emission
at 480 nm, 5 nm slit). **p<0.01, n=5.
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injection of cell permeable substrate, we
analyzed the aggregation level by PCA
assay. The results showed the luciferase
activity of cells cotransfected with A53TGLuc-N/C was larger than that of cells
cotransfected with α-Syn-GLuc-N/C (Fig.
5C). These date suggested A53T was more
prone to aggregate than WT α-Syn.
Since A53T was more prone to
aggregate than WT α-Syn, we then tested
our hypothesis that A53T could less
stimulate PP2A activity than WT α-Syn
in cells. The plasmids pCMV-myc-α-Syn
and pCMV-myc-A53T were transfected
into SK-N-SH cells respectively, and
the expression level of WT α-Syn and
A53T in transfected cells was first
confirmed to be at the comparable level
by immunocytochemistry (Fig. 6A) and
western blotting (Fig. 6B). Then we
measured PP2A activity in transfected
cells, and the results showed that the PP2A
activity in cells transfected with A53T was
lower than that in cells transfected with
WT α-Syn (Fig. 6C). These results implied
that A53T less stimulated PP2A activity
than WT α-Syn in cells.
Certainly, for this effect that A53T
less stimulated PP2A activity than WT
α-Syn in cells, there are two possibilities:
one possibility is that A53T mutation
per se has less effect on PP2A activity
upregulation, and the other possibility
is that A53T forms more aggregates and
consequently blocks the hydrophobic
domain of α-Syn which is associated
with the PP2A activity upregulation.
Thus, we have to exclude one possibility
from the other. To test the effect of A53T
mutation per se on the PP2A activity, we
first expressed and purified A53T protein
(Fig. 7A). WT α-Syn and A53T proteins
were incubated with PP2A Cα protein
respectively, and the results showed that
the PP2A activity in response to purified
A53T protein was similar with that of WT
α-Syn (Fig. 7B). These results indicated
that A53T mutation per se had similar
regulating effect on PP2A activity with
WT α-Syn, and the effect that A53T less
stimulated PP2A activity than WT α-Syn
in cells may be due to the formation of
more aggregates in A53T transfecting
cells.

Fig. 5. A53T was more prone to aggregate than
WT α-Syn. (A) The principle of protein-fragment
complementation assay based on Gaussia princeps
luciferase. (B) The protein levels, after paired constructs
transfected into SK-N-SH cells, were detected by
western blotting. β-actin was used as a loading control.
(C) 24 h after transfection, the cells were washed and
treated with the substrates (coelenterazine, 20 μM).
The luciferase activity was measured in an automated
plate reader at 480 nm. **p<0.01, n=5.

Fig.6

5

Fig. 6. A53T less stimulated the activity of PP2A
than WT α-Syn in cells. (A) The plasmids of α-Syn
(pCMV-myc-α-Syn) and A53T (pCMV-myc-A53T) were
transfected into SK-N-SH cells. After transfection 24
h, SK-N-SH cells were fixed and stained with antimyc antibodies (green). The nucleus was stained by
DAPI (blue). Scale bar, 25 μm. (B) Western blotting
was performed to determine α-Syn and A53T protein
expression levels in transfected SK-N-SH cells. β-actin
was used as a loading control. (C) 24 h after transfection
with plasmids into SK-N-SH cells, PP2A activity was
detected by colorimetric assay. *p<0.05, n=5.
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Together, the above results suggested that blocking the NAC domain of α-Syn declined
the upregulating effect on PP2A activity. In other words, the NAC domain was involved in the
process of α-Syn regulating PP2A activity.

The residue I123 in PP2A Cα played a role in its activity upregulation by α-Syn
Since the NAC domain of α-Syn interacted with PP2A Cα and upregulated its activity,
but it is not clear which site of PP2A Cα is responsible for its interaction with α-Syn. There
is a hydrophobic region in PP2A Cα [21], since our results showed that the hydrophobic
domain of α-Syn (NAC) could bind to PP2A Cα, we hypothesized that α-Syn might bind to
the hydrophobic region of PP2A Cα and upregulate its activity. To test our hypothesis, the
computational molecular docking was firstly performed to imitate the potential interaction
between α-Syn and PP2A Cα. The docking results showed that the interaction was mainly
clustered in the vicinity of I123 in PP2A Cα and the end of the NAC terminus of α-Syn (Fig. 8).
In order to further experimentally identify which site are responsible for PP2A Cα
upregulation by α-Syn, five amino acids in the hydrophobic region of PP2A Cα were mutated
to hydrophilic acid, resulting in mutants I123S, W200S, L243S, Y265S and C269S (Fig.
9A). These mutants were expressed in Fig.7
recombinant insect baculovirus, and
purified by affinity chromatography with
Ni-sepharose beads combined with gel
filtration chromatography (Fig. 9B). Then
these mutant proteins were respectively
incubated with α-Syn, and the interaction
was detected by the GST pull-down assay.
As shown in Fig. 9C, the mutants of PP2A
Cα (including W200S, L243S, Y265S and
C269S) were pulled down by α-Syn, except
I123S. These results implied that the Fig. 7. A53T protein showed similar effect on PP2A
I123 of PP2A Cα might be critical residue activity with WT α-Syn. (A) Purified A53T protein
mediating the interaction between α-Syn was detected by the CBB staining of SDS-PAGE gels.
and PP2A Cα.
(B) Purified A53T protein and WT α-Syn protein were
Since PP2A Cα I123S could not bind incubated with PP2A Cα for 0.5 h respectively, then
to α-Syn, we hypothesized α-Syn might PP2A activity was detected in vitro by the assay kit.
have less effect on its activity stimulation. **p<0.01, n=5.
So the purified α-Syn protein (0.5 mg/
ml) and PP2A Cα I123S (0.5 mg/ml) Fig. 8. The
were incubated in vitro, and then PP2A computational
activity in response to α-Syn was detected docking model
by the colorimetric assay. The results i l l u s t r a t e s
showed that the PP2A Cα I123S activity the
potential
in response to α-Syn was similar with the i n t e r a c t i o n
baseline activity (Fig. 9D). Here, there are between α-Syn
two possibilities for this observation: one and PP2A Cα. (A)
possibility is that I123S mutation per se The interaction
has effect on its activity, and the other between α-Syn
possibility is that α-Syn does not interact (red) and PP2A
with I123S and consequently block the Cα (cyan). The
PP2A activity regulation by α-Syn.
intermolecular
In order to exclude the effect of non-bond interaction between these two proteins were
mutant (I123S) of PP2A Cα per se on identified by using the Discovery Studio Visualizer. The
its activity, we compared the activity interaction is mainly clustered in the vicinity of ILE123
of PP2A Cα I123S and WT PP2A Cα. As of PP2A Cα and the end of the NAC domain of α-Syn. (B)
shown in Fig. 9D, the activity of I123S was The close view of the interaction between α-Syn and
comparable as the baseline PP2A activity. PP2A Cα.
Fig.8
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In other words, I123S per se could not affect
the PP2A activity. The above results together
suggested that the residue I123 in PP2A Cα
might play a role in its binding with α-Syn and
its activity upregulation, although we could not
exclude other residues which were potential for
this effect.

Fig.9

Discussion

In this study, we explored the molecular
mechanism of α-Syn regulating PP2A activity.
We found the NAC domain of α-Syn could
interact with PP2A Cα and increased its activity.
When the NAC domain was blocked during Fig. 9. The residue I123 of PP2A Cα might
α-Syn aggregation, α-Syn showed little effect play a role in its activity upregulation by α-Syn.
on PP2A activity upregulation. In addition, we (A) Schematic representation of I123, W200,
found the residue I123 of PP2A Cα might play a L243, Y265 and C269 residues in PP2A Cα.
role in its activity regulation by α-Syn. Together, (B) The purified PP2A Cα mutants (including
these results implied that α-Syn might bind I123S, W200S, L243S, Y265S and C269S) were
to PP2A Cα by hydrophobic interaction and detected by the CBB staining of SDS-PAGE
upregulate PP2A activity, and α-Syn aggregates gels. (C) GST pull-down assay was performed
could less stimulate the PP2A activity than to detect the interaction between α-Syn and
α-Syn monomers. These findings could be best PP2A Cα mutants. Purified α-Syn protein were
illustrated in Fig. 10 in terms of the protein incubated with PP2A Cα mutant proteins, then
the compounds were separated by SDS-PAGE
binding pattern and PP2A activity regulation.
We found that the NAC domain of α-Syn gels. Anti-His and anti-GST blots showed input
could interact with PP2A Cα, but the N terminus and pull-down fractions in GST pull-down assay.
and C terminus could not. From theoretical Input, PP2A Cα. (D) α-Syn and PP2A Cα I123S
perspective, the NAC terminus of α-Syn is a were incubated together, then PP2A activity
hydrophobic region, and it can bind to many was detected by colorimetric assay kit. *p<0.05,
moleculars and regulate their activity [6, 9, 44]. **p<0.01, n=5.
Here, we found that the NAC domain of α-Syn
could interact with PP2A Cα and upregulate its
activity. On the other side, PP2A is an important phosphatase, and the hydrophobic region of
PP2A Cα plays a chief role in its activity regulation. As is known, there is also a hydrophobic
region in PP2A Cα. Previous studies have shown that okadaic acid, an inhibitor of PP2A,
could bind to the hydrophobic region of PP2A Cα to inhibit its activity. Further, from the
homology model, the interaction between α-Syn and PP2A Cα was mainly clustered in the
NAC domain of α-Syn and the vicinity of I123 of PP2A Cα. So we hypothesized that the NAC
domain of α-Syn might bind to the hydrophobic region of PP2A Cα. Experimentally, our data
indeed showed that the NAC domain of α-Syn could bind to the hydrophobic region of PP2A
Cα and upregulate its activity, particularly the residue I123 of PP2A Cα.
α-Syn is a natively unfolded protein which is prone to aggregate, and α-Syn aggregates
are formed by the NAC domain which mediates the conformational changes from random
coil to a β-sheet structure [6]. Aggregated α-Syn is the major component of inclusions in PD
and other synucleinopathy brains, which indicates that α-Syn aggregation is relevant to the
pathogenesis of neurodegenerative diseases [8, 49]. We found α-Syn aggregates, blocking
the NAC domain, could less upregulate PP2A activity than α-Syn monomers. Previous studies
have shown the loss of PP2A activity was associated with α-Syn aggregation in DLB brain and
α-Syn triplication brain, which was consistent with our findings.
A53T, the first point mutation related to PD, is prone to form aggregates by blocking
the NAC domain to exhibit toxicity [9, 50]. In our study, we indeed confirmed A53T was
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Fig. 10

more prone to aggregate than WT α-Syn
using PCA, consequently we found A53T
could less upregulate PP2A activity than
WT α-Syn. Previous studies have shown
that aging A53T mice exhibited α-Syn
aggregation in olfactory and adrenal, and
aggregated A53T α-Syn is a poor stimulator
of PP2A activity [50], which was consistent
with our findings. These data further
suggested the NAC domain of α-Syn bound
Fig. 10. A proposed model of α-Syn regulating
to PP2A Cα and upregulated its activity.
PP2A plays essential roles in PP2A Cα activity. (A) α-Syn binds to the PP2A Cα by
neurodegenerative diseases. In PD, the hydrophobic interaction and regulates its activity.
upregulation of PP2A activity could reduce (B) α-Syn aggregates, in which the hydrophobic
the TH phosphorylation to decrease the domain was blocked, could less stimulate the activity
dopamine synthesis and increase the motor of PP2A than monomers.
deficits. Since we found the NAC domain of
α-Syn could bind to the hydrophobic center of PP2A Cα and upregulate its activity, blocking
the NAC domain of α-Syn or occupying the hydrophobic center of PP2A Cα would be potential
therapeutic methods of PD, since increasing the dopamine synthesis and alleviating the
motor symptoms.
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